Time-Restricted eating shows promise for psoriasis inflammation
NCT ID NCT04728165
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 5 times
Summary
This pilot study tested whether time-restricted feeding (eating all daily calories between 8am and 2pm, then fasting for 18 hours) could reduce inflammation in men with mild to moderate psoriasis. 27 participants (including healthy volunteers) stayed at the clinic for 4.5 days, wore glucose monitors, and completed meal tests. The study measured changes in immune cell activity and other markers of inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- time-restricted feeding (eating only between 8am and 2pm each day)
- What this could lead to
- If it works, this could point toward a simple dietary approach to help manage inflammation in psoriasis.
- What could go wrong
- This is a very small pilot study (27 people) that only looks at blood markers, not actual skin improvement. It may not lead to any practical treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new gel calm psoriasis Flare-Ups?
- Can a Once-Daily cream tame psoriasis in toddlers?
- Can a switch to guselkumab clear stubborn psoriasis?
- Can a new biologic clear stubborn psoriasis?
- Diet and exercise may tame psoriasis in kids — a trial puts it to the test
- Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates